Progressive medical device technology company Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) this morning announced that it continues to test its TherOZap technology against the Zika virus, following the advice of one of the top research laboratories in Canada. Per the update, a number of additional parameters have been added to the testing regime, with an aim of producing statistically relevant results. The company intends to report further information as it becomes available. “Therma Bright is awaiting the results of the current testing of its proprietary TherOZap technology against the Zika virus. We appreciate the prudence and thorough approach being conducted by the research lab carrying out the testing,” Rob Fia, CEO of Therma Bright, stated in the news release. “Therma Bright understands the importance of doing things right with an aim to produce statistically relevant results. We will not rush this process and respect the advice provided by the researchers working on this ground-breaking testing.”
To view the full press release, visit http://cnw.fm/2GFEe
About Therma Bright Inc.
Therma Bright is a progressive medical-device technology company focused on providing consumers with quality medical devices that address their dermatological needs. Clear and healthy skin for all is at the core of the company’s philosophy, as is the belief that such outcomes should not be a privilege for only those who can afford costly procedures and treatments. The company’s breakthrough proprietary technology delivers effective, noninvasive and pain-free skin care. For more information, visit the company’s website at www.ThermaBright.com
NOTE TO INVESTORS: The latest news and updates relating to THRBF are available in the company’s newsroom at http://cnw.fm/THRBF
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
